Poliovirus immunity among adults in the Democratic Republic of the Congo: a cross-sectional serosurvey.
Autorzy:
Alfonso VH; Department of Epidemiology, University of California, Los Angeles, USA.; McKing Consulting, Atlanta, GA, USA. Voorman A; Bill and Melinda Gates Foundation, Seattle, WA, USA. Hoff NA; Department of Epidemiology, University of California, Los Angeles, USA. WeldonWC; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Gerber S; Bill and Melinda Gates Foundation, Seattle, WA, USA. Gadoth A; Department of Epidemiology, University of California, Los Angeles, USA. Halbrook M; Department of Epidemiology, University of California, Los Angeles, USA. Goldsmith A; Department of Epidemiology, University of California, Los Angeles, USA. Mukadi P; National Institute for Biomedical Research (INRB), Kinshasa, Democratic Republic of the Congo. Doshi RH; Department of Epidemiology, University of California, Los Angeles, USA.; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA. Ngoie-Mwamba G; Expanded Programme on Immunization, Kinshasa, Democratic Republic of the Congo. Fuller TL; Center for Tropical Research, Institute of the Environment and Sustainability, University of California, Los Angeles, USA. Okitolonda-Wemakoy E; Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo. Muyembe-Tamfum JJ; National Institute for Biomedical Research (INRB), Kinshasa, Democratic Republic of the Congo. Rimoin AW; Department of Epidemiology, University of California, Los Angeles, USA. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2022 Jan 05; Vol. 22 (1), pp. 30. Date of Electronic Publication: 2022 Jan 05.
Assessment of immunity to polio among Rohingya children in Cox's Bazar, Bangladesh, 2018: A cross-sectional survey.
Autorzy:
Estivariz CF; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Bennett SD; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Lickness JS; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Feldstein LR; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. WeldonWC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Leidman E; Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Ehlman DC; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Khan MFH; World Health Organization, Dhaka, Bangladesh. Adhikari JM; United Nations Children's Fund, Dhaka, Bangladesh. Hasan M; United Nations Children's Fund, Dhaka, Bangladesh. Billah MM; Institute of Epidemiology, Disease Control and Research, Dhaka, Bangladesh. Oberste MS; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Alamgir ASM; Institute of Epidemiology, Disease Control and Research, Dhaka, Bangladesh. Flora MD; Institute of Epidemiology, Disease Control and Research, Dhaka, Bangladesh.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2020 Mar 31; Vol. 17 (3), pp. e1003070. Date of Electronic Publication: 2020 Mar 31 (Print Publication: 2020).
Survey of poliovirus antibodies in Borno and Yobe States, North-Eastern Nigeria.
Autorzy:
Gofama MM; University of Maiduguri Teaching Hospital, Maiduguri, Nigeria. Verma H; World Health Organization, Geneva, Switzerland. Abdullahi H; World Health Organization, Abuja, Nigeria. Molodecky NA; World Health Organization, Geneva, Switzerland. Craig KT; World Health Organization, Abuja, Nigeria. Urua UA; National Primary Health Care Development Agency, Abuja, Nigeria. Garba MA; University of Maiduguri Teaching Hospital, Maiduguri, Nigeria. Alhaji MA; University of Maiduguri Teaching Hospital, Maiduguri, Nigeria. WeldonWC; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Oberste MS; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Braka F; World Health Organization, Abuja, Nigeria. Muhammad AJG; National Primary Health Care Development Agency, Abuja, Nigeria. Sutter RW; World Health Organization, Geneva, Switzerland.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Sep 26; Vol. 12 (9), pp. e0185284. Date of Electronic Publication: 2017 Sep 26 (Print Publication: 2017).
Arm Paralysis After Routine Childhood Vaccinations: Application of Advanced Molecular Methods to the Causality Assessment of an Adverse Event After Immunization.
Autorzy:
Shaw J; Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University, Golisano Children's Hospital, Syracuse. Halsey NA; Institute for Vaccine Safety, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. Weinberg A; Departments of Pediatrics, Medicine and Pathology, Director, Molecular and Virology Clinical Laboratories, University of Colorado Denver, Aurora. Scott Schmid D; National Center for Immunizations and Respiratory Diseases, Division of Viral Diseases, Atlanta, Georgia. George KS; Laboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Clinical Professor, Department of Biomedical Sciences, University at Albany, SUNY. WeldonWC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia. Jordan M; Pediatrics, Divisions of Immunobiology, and Bone Marrow Transplantation and Immune Deficiency Cincinnati Children's Hospital/University of Cincinnati, Ohio. Bryant PW; Laboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Albany. LaRussa PS; Department of Pediatrics, Division of Pediatric Infectious Diseases, Columbia University, New York, New York. Bradshaw DY; Department of Neurology, Upstate Medical University, New York, New York. Harrington T; Centers for Disease Control and Prevention, National Center for Emerging, Zoonotic, and Infectious Diseases, Division of Healthcare Quality Promotion, Immunization Safety Office, Clinical Immunization Safety Assessment Project, Atlanta, Georgia. Gershon A; Columbia University College of Physicians and Surgeons, New York, New York.
Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes.
Autorzy:
Chan HT; Department of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA. Xiao Y; Department of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA. WeldonWC; Centers for Disease Control and Prevention, Atlanta, GA, USA. Oberste SM; Centers for Disease Control and Prevention, Atlanta, GA, USA. Chumakov K; Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA. Daniell H; Department of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA. .
Pokaż więcej
Źródło:
Plant biotechnology journal [Plant Biotechnol J] 2016 Nov; Vol. 14 (11), pp. 2190-2200. Date of Electronic Publication: 2016 Jun 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Seroprevalence of Poliovirus Antibodies in the United States Population, 2009-2010.
Autorzy:
Wallace GS; Division of Viral Diseases, Center for Disease Control and Prevention, Atlanta, Georgia. Curns AT; Division of Viral Diseases, Center for Disease Control and Prevention, Atlanta, Georgia. . WeldonWC; Division of Viral Diseases, Center for Disease Control and Prevention, Atlanta, Georgia. Oberste MS; Division of Viral Diseases, Center for Disease Control and Prevention, Atlanta, Georgia.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2016 Aug 05; Vol. 16, pp. 721. Date of Electronic Publication: 2016 Aug 05.
Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses.
Autorzy:
Muller DA; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia. Pearson FE; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia. Fernando GJ; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia. Agyei-Yeboah C; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia. Owens NS; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia. Corrie SR; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia. Crichton ML; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia. Wei JC; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia. WeldonWC; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Oberste MS; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Young PR; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.; School of Chemical and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia. Kendall MA; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 Feb 25; Vol. 6, pp. 22094. Date of Electronic Publication: 2016 Feb 25.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
